Laxmi Organic Industries Ltd
Laxmi Organic Industries Limited was established in 1989 and is in the business of specialty chemicals. The Company primarily manufactures Ethyl Acetate, Acetic Acid and Diketene Derivative Products (DDP). DDP is a specialty chemical group, the technology and business of which has been acquired by the company from Clariant Chemicals India Limited.
The company’s business operations are carried in over 30 countries including 11 offices located in India
- Market Cap ₹ 4,752 Cr.
- Current Price ₹ 171
- High / Low ₹ 280 / 160
- Stock P/E 51.0
- Book Value ₹ 70.0
- Dividend Yield 0.30 %
- ROCE 8.77 %
- ROE 6.16 %
- Face Value ₹ 2.00
Pros
- Company's working capital requirements have reduced from 20.9 days to 11.2 days
Cons
- Company has a low return on equity of 7.72% over last 3 years.
- Dividend payout has been low at 11.5% of profits over last 3 years
- Promoter holding has decreased over last 3 years: -3.16%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 902 | 1,008 | 1,273 | 1,429 | 1,359 | 1,606 | 2,877 | 2,691 | 2,824 | 2,945 | 2,860 | |
| 825 | 892 | 1,124 | 1,275 | 1,239 | 1,401 | 2,541 | 2,444 | 2,566 | 2,655 | 2,655 | |
| Operating Profit | 76 | 116 | 149 | 154 | 120 | 205 | 337 | 247 | 258 | 289 | 205 |
| OPM % | 8% | 12% | 12% | 11% | 9% | 13% | 12% | 9% | 9% | 10% | 7% |
| 3 | 2 | 4 | 6 | 33 | 9 | 21 | 29 | 29 | 19 | 20 | |
| Interest | 18 | 11 | 10 | 16 | 15 | 18 | 17 | 22 | 6 | 20 | 20 |
| Depreciation | 28 | 27 | 29 | 41 | 48 | 45 | 47 | 70 | 105 | 122 | 106 |
| Profit before tax | 32 | 81 | 113 | 103 | 90 | 151 | 294 | 183 | 176 | 166 | 99 |
| Tax % | 23% | 12% | 32% | 24% | 13% | 19% | 18% | 27% | 28% | 29% | |
| 25 | 71 | 77 | 78 | 79 | 123 | 240 | 135 | 127 | 118 | 93 | |
| EPS in Rs | 24.56 | 70.71 | 76.66 | 15.54 | 17.46 | 4.65 | 9.09 | 5.08 | 4.62 | 4.26 | 3.36 |
| Dividend Payout % | 4% | -0% | -0% | 2% | 10% | 11% | 8% | 10% | 13% | 12% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 17% |
| 3 Years: | 1% |
| TTM: | -3% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 15% |
| 3 Years: | -22% |
| TTM: | -42% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | -18% |
| 1 Year: | -36% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 11% |
| 3 Years: | 8% |
| Last Year: | 6% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 10 | 10 | 10 | 50 | 45 | 53 | 53 | 53 | 55 | 55 | 55 |
| Reserves | 224 | 294 | 370 | 405 | 396 | 992 | 1,230 | 1,367 | 1,745 | 1,857 | 1,885 |
| 199 | 79 | 194 | 143 | 138 | 75 | 99 | 372 | 139 | 255 | 331 | |
| 158 | 227 | 258 | 359 | 445 | 616 | 785 | 537 | 880 | 874 | 925 | |
| Total Liabilities | 590 | 610 | 832 | 958 | 1,024 | 1,735 | 2,166 | 2,329 | 2,820 | 3,040 | 3,196 |
| 207 | 195 | 273 | 327 | 327 | 315 | 361 | 694 | 872 | 1,161 | 1,432 | |
| CWIP | 33 | 48 | 30 | 31 | 23 | 60 | 177 | 88 | 459 | 419 | 483 |
| Investments | 19 | 23 | 20 | 20 | 21 | 25 | 32 | 287 | 149 | 167 | 82 |
| 332 | 344 | 509 | 579 | 653 | 1,335 | 1,597 | 1,259 | 1,341 | 1,294 | 1,199 | |
| Total Assets | 590 | 610 | 832 | 958 | 1,024 | 1,735 | 2,166 | 2,329 | 2,820 | 3,040 | 3,196 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| 135 | 110 | 61 | 161 | 521 | 114 | |||||
| -3 | -604 | 44 | -362 | -494 | -274 | |||||
| -115 | 485 | -87 | 241 | -10 | 91 | |||||
| Net Cash Flow | 17 | -9 | 17 | 40 | 16 | -68 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 61 | 78 | 83 | 78 | 85 | 87 | 79 | 73 | 78 | 67 |
| Inventory Days | 61 | 34 | 51 | 48 | 57 | 59 | 60 | 50 | 48 | 68 |
| Days Payable | 70 | 85 | 83 | 112 | 154 | 155 | 127 | 93 | 146 | 133 |
| Cash Conversion Cycle | 52 | 27 | 51 | 13 | -12 | -8 | 12 | 30 | -20 | 3 |
| Working Capital Days | 12 | 16 | 25 | 27 | 34 | 5 | 42 | 33 | 18 | 11 |
| ROCE % | 22% | 26% | 20% | 14% | 20% | 25% | 13% | 9% | 9% |
Documents
Announcements
- Shareholder Meeting / Postal Ballot-Scrutinizer"s Report 8m
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
21 Nov - Laxmi Organic Industries Limited has submitted copies of Newspaper Advertisement published in Business Standard and Sakal on November 21, 2025, pertaining to varying/altering the objects …
-
Announcement under Regulation 30 (LODR)-Credit Rating
20 Nov - CRISIL revised Laxmi Organic's long-term outlook to Negative from Stable; CRISIL AA/A1+ reaffirmed (Nov 20, 2025).
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
10 Nov - The Officials of the Company will be attending an Investor Conference hosted by Kotak Securities Limited to be held on November 20, 2025. The detailed …
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
10 Nov - The officials of the Company will be attending an Investor Conference hosted by Anand Rathi Institutional Equities on November 13, 2025. The detailed disclosure is …
Annual reports
Concalls
-
Nov 2025Transcript PPT REC
-
Aug 2025Transcript PPT REC
-
May 2025Transcript PPT
-
May 2025TranscriptAI SummaryPPT
-
Jan 2025Transcript PPT
-
Nov 2024Transcript PPT
-
Aug 2024Transcript PPT
-
Jul 2024TranscriptAI SummaryPPT
-
May 2024Transcript PPT REC
-
Feb 2024Transcript PPT
-
Oct 2023Transcript PPT REC
-
Oct 2023TranscriptAI SummaryPPT
-
Aug 2023Transcript PPT
-
Jul 2023TranscriptAI SummaryPPT
-
May 2023TranscriptPPT
-
May 2023Transcript PPT
-
Jan 2023Transcript PPT
-
Nov 2022Transcript PPT
-
Nov 2022TranscriptAI SummaryPPT
-
Aug 2022Transcript PPT
-
Jul 2022TranscriptAI SummaryPPT
-
May 2022TranscriptAI SummaryPPT
-
Feb 2022TranscriptAI SummaryPPT
-
Nov 2021TranscriptAI SummaryPPT
-
Aug 2021TranscriptAI SummaryPPT
-
May 2021Transcript PPT
Product Portfolio[1]
a) Essentials Segment
The Segment includes products like Ethyl Acetate, Acetic Anhydride, Acetaldehyde, various solvents, ethanol, and n-Butyl/Ethyl Acetate. These cater primarily to the pharmaceutical, packaging, and industrial sectors.